SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for VERA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Cogent Biosciences, Inc. 23.93M
Syndax Pharmaceuticals, Inc. 49.93M
United Therapeutics Corp. 160.80M
Cytokinetics, Inc. 91.72M
Insmed, Inc. 212.48M